Seeger JD, Loughlin J, Rivero E, Earnest DL, Quinn SG, Huang J, Rueegg P, Dennis E, Kralstein J. No evidence for association of tegaserod with cardiovascular adverse ischemic events (CVIE) in routine clinical practice. Presented at the Annual Meeting of the American College of Gastroenterology; October 2008. Orlando, FL.
Arellano FM, Yood MU, Wentworth CE, Oliveria SA, Rivero E, Arana A, Rothman KJ. Use of Cyclo-Oxygenase 2 Inhibitors (COX-2) and prescription Non-Steroidal Anti-Inflammatory Drugs (NSAIDS) in UK and USA populations. Pharmacoepidemiol Drug Saf. 2008 Oct 1;17(10):1037. doi: 10.1002/pds.1636
Arana A, Arellano FM, Rivero E, Pavesi M, Dey D, Wentworth CW. Intravitreal (IVT) injection-related ocular adverse events in the general population of the United States of America. Poster presented at the 24th International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2008. Copenhagen, Denmark. [abstract] Pharmacoepidemiol Drug Saf. 2008 Aug; 17(Suppl 1):S75-6.
Wentworth CW, Arellano FM, Rivero E, Pavesi M, Dey D, Arana A. Use of intravitreal (IVT) injection therapies in the general population of the United States of America. Presented at the 24th International Conference on Pharmacoepidemiology; August 2008. Copenhagen, Denmark. [abstract] Pharmacoepidemiol Drug Saf. 2008 Aug; 17(Suppl 1):S251-2.